Scientific Publications by Lundbeck employees
|
For more information, please click here to access the Lundbeck Clinical Trial Registry. |
| Publication title | Author | Source | Drug | Year |
| Gauge-origin independent magnetizabilities from hybrid quantum mechanics/molecular mechanics models: Theory and applications to liquid water | Aidas K, Kongsted J, Nielsen CB, Mikkelsen KV, Christiansen O, Ruud K | Chemical Physics Letters 2007;442(4-6):322-328 | - | 2007 |
| A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder | Wade A, Gembert K, Florea I | Current Medical Research and Opinion 2007;23(7):1605-1614 | Citalopram; Escitalopram | 2007 |
| Discontinuation symptoms in depression and anxiety disorders | Baldwin DS, Montgomery SA, Nil R, Lader M | International Journal of Neuropsychopharmacology 2007;10(1):73-84 | Escitalopram | 2007 |
| Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies | El Mansari M, Wiborg O, Mnie-Filali O, Benturquia N, Sanchez C, Haddjeri N | International Journal of Neuropsychopharmacology 2007;10(1):31-40 | Citalopram; Escitalopram | 2007 |
| Escitalopram in the treatment of anxiety symptoms associated with depression | Bandelow B, Andersen HF, Dolberg OT | Depression and anxiety 2007;24(1):53-61 | Citalopram; Escitalopram | 2007 |
| An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents | Bundgaard C, Jorgensen M, Mork A | Journal of Pharmacological and Toxicological Methods 2007;55(2):214-223 | Citalopram; Escitalopram | 2007 |
| A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety | Olie JP, Tonnoir B, Menard F, Galinowski A | Depression and anxiety 2007;24(5):318-324 | Escitalopram | 2007 |
| Escitalopram and citalopram: The unexpected role of the R-enantiomer | Jacquot C, David DJ, Gardier AM, Sanchez C | Encephale 2007;33(2):179-187 | Citalopram; Escitalopram | 2007 |
| Inactivation as a New Regulatory Mechanism for Neuronal Kv7 Channels | Jensen HSl, Grunnet M, Olesen SP | Biophysical Journal 2007;92(8):2747-2756 | - | 2007 |
| Nuclear magnetic shielding constants of liquid water: Insights from hybrid quantum mechanics/molecular mechanics models | Kongsted J, Nielsen CB, Mikkelsen KV, Christiansen O, Ruud K | Journal of chemical physics 2007;126(3):034510-1 - 034510-8 | - | 2007 |
| The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia | Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, Gerald CP | Genes Brain and Behavior 2007;6(7):628-639 | - | 2007 |
| Pharmacokinetic/Pharmacodynamic feedback modelling of the functional corticosterone response in rats after acute treatment with escitalopram | Bundgaard C, Larsen F, Jorgensen M, Mork A | Basic and clinical pharmacology and toxicology 2007;100(3):182-189 | Citalopram; Escitalopram | 2007 |
| Synthesis and preliminary pharmacological evaluation of the four stereoisomers of (2S)-2-(2'-phosphono-3'-phenylcyclopropyl)glycine, the first class of 3'-substituted transC1'-2'-2-(2'-phosphonocyclopropyl) glycines | Marinozzi M, Serpi M, Amori L, Gavilan Diaz M, Costantino G, Meyer U, Flor PJ, Gasparini F, Heckendorn R, Kuhn R, Giorgi G, Brunsgaard Hermit M, Thomsen C, Pellicciari R | Bioorganic and Medicinal Chemistry 2007;15(9):3161-3170 | - | 2007 |
| Escitalopram in obsessive-compulsive disorder: A randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study | Stein DJ, Andersen EW, Tonnoir B, Fineberg N | Current Medical Research and Opinion 2007;23(4):701-711 | Citalopram; Escitalopram | 2007 |
| Safety and Efficacy of Oral Escitalopram as Continuation Treatment of Intravenous Citalopram in Patients with Major Depressive Disorder | Schmitt L, Tonnoir B, Arbus C | Neuropsychobiology 2007;54(4):201-207 | Citalopram; Escitalopram | 2007 |
| The potential therapeutic use of phosphodiesterase 10 inhibitors | Kehler J, Ritzen A, Greve DR | Expert Opinion on Therapeutic Patents 2007;17(2):147-158 | - | 2007 |
| Novel 5-Substituted 1-Pyrazolol Analogues of Ibotenic Acid: Synthesis and Pharmacology at Glutamate Receptors | Jorgensen CG, Brauner-Osborne H, Nielsen B, Kehler J, Clausen RP, Krogsgaard-Larsen P, Madsen U | Bioorganic and Medicinal Chemistry 2007. Article in Press, Accepted Manuscript: 3 March 2007 | - | 2007 |
| Escitalopram in major depressive disorder: Clinical benefits and cost effectiveness versus citalopram | Lancon C, Verpillat P, Annemans L, Despiegel N, Francois C | International Journal of Psychiatry in Clinical Practice 2007;11(1):44-52 | Citalopram; Escitalopram | 2007 |
| Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives | Villa P, Van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, Brines M, Leist M, Ghezzi P, Torup L | Journal of Cerebral Blood Flow and Metabolism 2007;27(3):552-563 | - | 2007 |
| A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application | Baroni M, Cruciani G, Sciabola S, Perruccio F, Mason JS | Journal of Chemical Information and Modeling 2007;47(2):279-294 | - | 2007 |
| Nanoporous magnesium aluminometasilicate tablets for precise, controlled, and continuous dosing of chemical reagents and catalysts: applications in parallel solution-phase synthesis | Ruhland T, Nielsen SD, Holm P, Christensen CH | Journal of Combinatorial Chemistry 2007;9(2):301-305 | - | 2007 |
| 4-Aryl-5-(4-Piperidyl)-3-Isoxazolol GABA(A) Antagonists: Synthesis, Pharmacology, and Structure-Activity Relationships | Frolund B, Jensen LS, Storustovu SI, Stensbol TB, Ebert B, Kehler J, Krogsgaard-Larsen P, Liljefors T | Journal of Medicinal Chemistry 2007;50(8):1988-1992 | Gaboxadol | 2007 |
| Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils | Selenica ML, Wang X, Ostergaard Pedersen L, Westlind Danielsson A, Grubb A | Scandinavian Journal of Clinical and Laboratory Investigation 2007;67 (2):179-190 | - | 2007 |
| Probing the Pharmacophore of Ginkgolides as Glycine Receptor Antagonists | Jensen AA, Begum Nasreen, Vogensen SB, Knapp Kolja M, Gundertofte K, Dzyuba Sergei V, Ishii Hideki, Nakanishi Koji, Kristiansen U, Stromgaard K | Journal of Medicinal Chemistry 2007;50(7):1610-1617 | - | 2007 |
| Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia | Deacon S, Staner L, Staner C, Legters A, Loft H, Lundahl J | Sleep 2007;30(3):281-287 | Gaboxadol | 2007 |
H. Lundbeck A/S
Ottiliavej 9
DK-2500 Copenhagen Valby
Ottiliavej 9
DK-2500 Copenhagen Valby
Tel +45 36 30 13 11
Fax +45 36 30 19 40
Fax +45 36 30 19 40
The specialist in psychiatry and pioneer in neurology
Disclaimer & Privacy statement
Disclaimer & Privacy statement